ArisGlobal, a provider of life sciences technology spanning pharmacovigilance, regulatory, medical affairs, clinical, and quality functions, developed NavaX, an AI engine purpose-built for life sciences on Amazon Bedrock, to automate adverse-event case processing. ArisGlobal chose Amazon Bedrock for managed access to foundation models, EU geographic cross-Region inference, and managed prompt caching. As enterprise customers added distinct compliance requirements, the shared prompt prefix grew by about 150% over 6 months, while per-case inference costs increased by more than 200%.
ArisGlobal first cached each source document because it was the largest part of a request. That left the growing shared prompt prefix outside the cache. By reversing the order and caching the shared prefix instead, ArisGlobal reduced effective input cost and supported additional tenants without proportional cost growth.
ArisGlobal is the creator of LifeSphere, a unified SaaS platform for pharmacovigilance, regulatory affairs, quality, and medical information. LifeSphere serves pharmaceutical companies globally, including multiple Top 20 pharma organizations by revenue (source: ArisGlobal press release). The entire system runs on AWS.
LifeSphere NavaX is ArisGlobal’s AI engine that transforms drug safety from a system of record into a system of strategic advantage. ArisGlobal productionized their first generative AI solution on Amazon Bedrock with Anthropic’s Claude in March 2025. According to ArisGlobal’s internal production telemetry, they have processed over 1 million real transactions in regulated pharmaceutical environments, handling billions of tokens across multiple enterprise tenants. Model availability varies by Region. See Model support by AWS Region.
When a pharmaceutical company receives an adverse-event report, typically a multipage PDF describing a patient’s reaction to a medication, NavaX’s Dynamic Data Extraction (DDE) agent extracts around 130 fields.
Source link







